Summary
The effects of serotonin receptor agonists and antagonists on the electrically (3 Hz) evoked 3H overflow were determined on pig brain cortex slices preincubated with 3H-serotonin and superfused with physiological salt solution containing indalpine (an inhibitor of serotonin uptake) plus phentolamine. The potencies of the serotonin receptor agonists and antagonists were compared with their affinities for 5-HT1A, 5-HT1B, 5-HT1c, and 5-HT1D binding sites in pig or rat tissue membranes; in addition, the potencies of the agonists were compared to their potencies in inhibiting adenylate cyclase activity in membranes of calf substantia nigra. In the superfusion experiments on pig brain cortex slices the following rank orders of potencies were obtained: agonists, serotonin > 5-methoxytryptamine = 5-carboxamidotryptamine >R U 24969 (5-methoxy-3(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole) > SDZ 21009 (4(3-terbutylamino- 2-hydroxypropoxy)indol- 2-carbonic-acid-isopropylester) ≥ yohimbine ≥ cyanopindolol > 8-OHDPAT (8-hydroxy-2-(di-n-propylamino)tetralin) ≥ CGS 12066 B (7-trifluoromethyl-4(4-methyl-l-piperazinyl)-pyrrolo[1,2-a]quinoxaline); ipsapirone and urapidil were ineffective; antagonists (antagonism determined against 5methoxytryptamine as an agonist), metitepine > metergoline > mianserin. Propranolol, spiperone or mesulergine did not produce a shift of the concentration-response curve for 5-methoxytryptamine. The potencies of the serotonin receptor agonists in pig brain cortex slices were significantly correlated with their affinities for 5-HT1c and 5-HT1D binding sites in membranes of the pig choroid plexus and caudate nucleus, respectively, but not with their affinities for 5-HT1A and 5-HT1B sites in membranes of the cerebral cortex of pig and rat, respectively. The agonist potencies in decreasing 3H overflow were also significantly correlated with their potencies in inhibiting adenylate cylase activity in calf substantia nigra (i.e., a 5-HT1D receptor-mediated effect). In conclusion, the pig brain cortical 5-HT autoreceptor probably belongs to the 5-HT1D subtype. The involvement of 5-HT1c recognition sites was excluded by the low potency of mianserin as an antagonist and, in particular, by the ineffectiveness of the 5-HT1c receptor antagonist mesulergine.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bonanno G, Maura G, Raiteri M (1986) Pharmacological characterization of release-regulating serotonin autoreceptors in rat cerebellum. Eur J Pharmcol 126:317–321
Crist J, Surprenant A (1987) Evidence that 8-hydroxy-2-(n-dipropylamino) tetralin (8-OH-DPAT) is a selective α2-adrenoceptor antagonist on guinea-pig submucous neurones. Brit J Pharmacol 92:341–347
Engel G, Göthert M, Müller-Schweinitzer E, Schlicker E, Sistonen L, Stadler PA (1983) Evidence for common pharmacological properties of [3H]5-hydroxytryptamine binding sites, presynaptic 5-hydroxytryptamine autoreceptors in CNS and inhibitory presynaptic 5-hydroxytryptamine receptors on sympathetic nerves. Naunyn-Schmiedeberg's Arch Pharmacol 324:116–124
Engel G, Göthert M, Hoyer D, Schlicker E, Hillenbrand K (1986) Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites. Naunyn-Schmiedeberg's Arch Pharmacol 332:1–7
Feuerstein TJ, Lupp A, Hertting G (1987) The serotonin (5-HT) autoreceptor in the hippocampus of the rabbit: role of 5-HT biophase concentration.Neuropharmacology 26:1071–1080
Fink K, Schlicker E, Betz R, Göthert M (1988) Identification of presynaptic 5-HT1 autoreceptors in pig brain cortex synaptosomes and slices. Naunyn-Schmiedeberg's Arch Pharmacol 338:14–18
Furchgott RF (1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Blaschko H, Muscholl E (eds) Handbook of exper imental pharmacology, vol XXXIII. Springer, Berlin Heidelberg New York, pp 283–335
Galzin AM, Chodkiewicz JP, Poirier MF, Loo H, Roux FX, Redondo A, Lista A, Ramdine R, Blier P, Langer SZ (1988) Modulation of the electrically-evoked release of [3H]-5-HT from slices of human frontal cortex. Brit J Pharmacol 93:14 P
Göthert M (1982) Modulation of serotonin release in the brain via presynaptic receptors. Trends Pharmacol Sci 3:437–440
Göthert M (1985) Role of autoreceptors in the function of the peripheral and central nervous system. Arzneimittelforschung 35:1909–1916
Göthert M (1986) Serotonin receptors in the circulatory system. In: van Zwieten PA, Schönbaum E (eds) Progress in pharmacology, vol 6/2. Fischer, Stuttgart New York, pp 155–172
Göthert M (1987) Inhibitory actions of serotonin (5-HT) on peripheral and central neurones. In: Rand MJ, Raper C (eds) Pharmacology, Excerpta Medica, International Congress Series No. 750. Elsevier, Amsterdam, pp 289–293
Göthert M, Huth H, Schlicker E (1981) Characterization of the receptor subtype involved in alpha-adrenoceptor-mediated modulation of serotonin release from rat brain cortex slices. Naunyn-Schmiedeberg's Arch Pharmacol 317:199–203
Hoyer D (1988) Functional correlates of serotonin 5-HT1 recognition sites. J Recept Res 8:59–81
Jackisch R, Kasakov L, Feuerstein TJ, Hertting G (1987) Effects of urapidil on neurotransmitter release in CNS tissue in vitro. Arch Int Pharmacodyn 285:5–24
Limberger N, Bonanno G, Späth L, Starke K (1986) Autoreceptors and α2-adrenoceptors at the serotonergic axons of rabbit brain cortex. Naunyn-Schmiedeberg's Arch Pharmacol 332:324–331
Maura G, Roccatagliata E, Raiteri M (1986) Serotonin autoreceptor in rat hippocampus: Pharmacological characterization as a subtype of the 5-HT1 receptor. Naunyn-Schmiedeberg's Arch Pharmacol 334:323–326
Middlemiss DN, Bremer ME, Smith SM (1988) A pharmacological analysis of the 5-HT receptor mediating inhibition of 5-HT release in the guinea-pig frontal cortex. Eur J Pharmacol 157:101–107
Moret C (1985) Pharmacology of the serotonin autoreceptor. In: Green AR (ed) Neuropharmacology of serotonin. Oxford University Press, Oxford New York Toronto Melbourne, pp 21–49
Neale RF, Fallon SL, Boyar WC, Wasley JWF, Martin LL, Stone GA, Glaeser BS, Sinton CM, Williams M (1987) Biochemical and pharmacological characterization of CGS 12066 B, a selective serotonin-1B agonist. Eur J Pharmacol 136:1–9
Peroutka SJ (1988) 5-Hydroxytryptamine receptor subtypes. Annu Rev Neurosci 11:45–60
Rimele TJ, Henry DE, Lee DKH, Geiger G, Heaslip RJ, Grimes D (1987) Tissue-dependent alpha adrenoceptor activity of buspirone and related compounds. J Pharmacol Exp Ther 241:771–778
Sachs L (1983) Angewandte Statistik. Anwendung statistischer Methoden. Springer, Berlin Heidelberg New York Tokyo
Schipper J, van der Heyden JAM, Olivier B (1987) Species differences in serotonin autoreceptors. Soc Neurosci Abstr vol 13, I, 345
Schlicker E, Brandt F, Classen K, Göthert M (1985a) Serotonin release in human cerebral cortex and its modulation via serotonin receptors. Brain Res 331:337–341
Schlicker E, Göthert M, Hillenbrand K (1985b) Cyanopindolol is a highly potent and selective antagonist at the presynaptic serotonin autoreceptor in the rat brain cortex. NaunynSchmiedeberg's Arch Pharmacol 331:398–401
Schlicker E, Fink K, Betz R, Göthert M (1988a) The serotonin autoreceptor in the pig brain cortex belongs to the 5-HT1D receptor subtype. Naunyn-Schmiedeberg's Arch Pharmacol 338 (Suppl.):R67
Schlicker E, Molderings G, Betz R, Göthert M (1988 b) Antagonistic properties of RU 24969, a preferential 5-HT1 receptor agonist, at presynaptic α2-adrenoceptors of central and peripheral neurones. Pharmacol Toxicol 63:281–285
Schoeffter P, Waeber C, Palacios JM, Hoyer D (1988) The 5hydroxytryptamine 5-HT1D receptor subtype is negatively coupled to adenylate cyclase in calf substantia nigra. NaunynSchmiedeberg's Arch Pharmacol 337:602–608
Starke K (1981) α-Adrenoceptor subclassification. Rev Physiol Biochem Pharmacol 88:199–236
Starke K, Montel H, Gayk W, Merker R (1974) Comparison of the effects of clonidine on pre- and postsynaptic adrenoceptors in the rabbit pulmonary artery. α-Sympathomimetic inhibition of neurogenic vasoconstriction. Naunyn-Schmiedeberg's Arch Pharmacol 285:133–150
Starke K, Göthert M, Kilbinger H (1989) Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol Rev, in press
Timmermans PBMWM, Thoolen MJMC (1987) Autoreceptors in the central nervous system. Med Res Rev 7:307–332
Waeber C, Schoeffter P, Palacios JM, Hoyer D (1988) Molecular pharmacology of 5-HT1D recognition sites: radioligand binding studies in human, pig and calf brain membranes. NaunynSchmiedeberg's Arch Pharmacol 337:595–601
Author information
Authors and Affiliations
Additional information
E. S. and M. G. were supported by grants of the Deutsche Forschungsgemeinschaft
Send offprint requests to M. Göthert at the above address
Rights and permissions
About this article
Cite this article
Schlicker, E., Fink, K., Göthert, M. et al. The pharmacological properties of the presynaptic serotonin autoreceptor in the pig brain cortex conform to the 5-HT1D receptor subtype. Naunyn-Schmiedeberg's Arch Pharmacol 340, 45–51 (1989). https://doi.org/10.1007/BF00169206
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00169206